Medical Weight Management For Women + Men

Weight Loss Is More Than a Number on the Scale.

Sustainable weight management starts with understanding the health behind the weight.
At MOKI, we look beyond calories and the scale to evaluate your metabolic health, cardiovascular risk, hormones, thyroid function, micronutrients, medical history, and individual goals—then build a treatment plan designed around you.

Every new patient begins with comprehensive laboratory testing, a one-on-one provider consultation, and a personalized treatment plan.

Let’s chat

The Scale Is One Measurement. Your Health Is the Bigger Picture.

Losing weight can improve health—but simply making the number on the scale smaller doesn’t automatically address everything happening underneath it.

Metabolic health. Cardiovascular risk. Hormonal changes. Thyroid function. Nutrient deficiencies. Sleep. Medications. Lifestyle. Family history.

They can all be part of the picture.

We start by looking for what else needs our attention.
Your MOKI Evaluation helps us identify health concerns, risk factors, deficiencies, and other clinical findings that may influence your treatment plan—so we’re not simply treating the weight while overlooking the health behind it.

Because treating the symptom without addressing the bigger picture is like cleaning up the water without fixing the leak
weight-loss Solutions

GLP-1 Medication + Weight Management

Thoughtful medical management.

Medications such as semaglutide and tirzepatide have changed the way obesity and overweight with weight-related conditions can be medically treated.

These medications affect pathways involved in appetite, satiety, food intake, and metabolic regulation. For appropriately selected patients, they may be one component of a comprehensive medical weight-management plan.

At MOKI, medication therapy is individualized based on your medical history, treatment goals, response, tolerability, contraindications, and ongoing clinical assessment.

Prescription options may include FDA-approved medications and, when clinically appropriate and legally available, compounded medications. Your provider will discuss the differences, indications, limitations, risks, benefits, and pricing applicable to your treatment options.

Semaglutide


A GLP-1 receptor agonist used in FDA-approved formulations for certain patients with obesity or overweight with weight-related conditions.

starting at $150/month

*medication pricing varies by dose. must have an active MOKI membership.

Tirzepatide


A dual GIP/GLP-1 receptor agonist used in FDA-approved formulations for certain patients with obesity or overweight with weight-related conditions.

starting at $250/month

*medication pricing varies by dose. must have an active MOKI membership.